Matthew M. Gosling
2013
In 2013, Matthew M. Gosling earned a total compensation of $947.1K as Senior Vice President and General Counsel at DepoMed, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,636 |
|---|---|
| Option Awards | $196,063 |
| Salary | $380,047 |
| Stock Awards | $206,485 |
| Other | $7,894 |
| Total | $947,125 |
Gosling received $380K in salary, accounting for 40% of the total pay in 2013.
Gosling also received $156.6K in non-equity incentive plan, $196.1K in option awards, $206.5K in stock awards and $7.9K in other compensation.
Rankings
In 2013, Matthew M. Gosling's compensation ranked 6,877th out of 12,286 executives tracked by ExecPay. In other words, Gosling earned more than 44.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,877 out of 12,286 | 44th |
Division Manufacturing | 2,441 out of 4,612 | 47th |
Major group Chemicals And Allied Products | 740 out of 1,466 | 50th |
Industry group Drugs | 547 out of 1,160 | 53rd |
Industry Pharmaceutical Preparations | 433 out of 890 | 51st |
Source: SEC filing on April 14, 2016.
Gosling's colleagues
We found four more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2013.